Public Act 097-0049
 
SB1805 EnrolledLRB097 05294 RPM 45348 b

    AN ACT concerning public health.
 
    Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
 
    Section 5. The Department of Public Health Powers and
Duties Law of the Civil Administrative Code of Illinois is
amended by changing Section 2310-312 as follows:
 
    (20 ILCS 2310/2310-312)
    Sec. 2310-312. Multidrug-Resistant Organisms. The
Department shall perform the following functions in relation to
the prevention and control of Multidrug-Resistant Organisms
(MDROs), including methicillin-resistant Staphylococcus aureus
(MRSA), vancomycin-resistant (VRE) and certain gram-negative
bacilli (GNB), as these terms are referenced by the United
States Centers for Disease Control and Prevention:
        (1) Except with regard to hospitals, for which
    administrative rules shall be adopted in accordance with
    Section 6.23 of the Hospital Licensing Act and Section 7 of
    the University of Illinois Hospital Act, the Department
    shall adopt administrative rules for health care
    facilities subject to licensure, certification,
    registration, or other regulation by the Department that
    may require one or more types of those facilities to (i)
    perform an annual infection control risk assessment, (ii)
    develop infection control policies for MDROs that are based
    on this assessment and incorporate, as appropriate,
    updated recommendations of the U.S. Centers for Disease
    Control and Prevention for the prevention and control of
    MDROs, and (iii) enforce hand hygiene requirements.
        (2) The Department shall:
            (A) publicize guidelines for reducing the
        incidence of MDROs to health care providers, health
        care facilities, public health departments, prisons,
        jails, and the general public; and
            (B) provide periodic reports and updates to public
        officials, health professionals, and the general
        public statewide regarding new developments or
        procedures concerning prevention and management of
        infections due to MDROs.
        (3) The Department shall publish a yearly report
    regarding MRSA and Clostridium difficile infections based
    on the Centers for Disease Control and Prevention's
    National Healthcare Safety Network surveillance system or
    its successor the Hospital Discharge Dataset. The
    Department is authorized to require hospitals, based on
    guidelines developed by the National Center for Health
    Statistics, after October 1, 2007, to submit data to the
    Department that is coded as "present on admission" and
    "occurred during the stay".
        (4) Reporting to the Department under the Hospital
    Report Card Act shall include organisms, including but not
    limited to MRSA, that are responsible for central venous
    catheter-associated bloodstream infections and
    ventilator-associated pneumonia in designated hospital
    units.
        (5) The Department shall implement surveillance for
    designated cases of community associated MRSA infections
    for a period of at least 3 years, beginning on or before
    January 1, 2008.
(Source: P.A. 95-282, eff. 8-20-07.)